Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival

.

Source: OncoImmunology - March 24, 2019 Category: Cancer & Oncology Authors: Abdulla Watad Dennis McGonagle Nicola L. Bragazzi Shmuel Tiosano Doron Comaneshter Yehuda Shoenfeld Arnon D. Cohen Howard Amital Source Type: research